ELEVANCE HEALTH, INC. — Operating Income by Fiscal Year
18 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/26847097-6ae5-4126-ac68-90cb014786f3/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $7.2B | 2025-01-01 – 2025-12-31 | evidence 0001156039-26-000013 |
| FY 2024 | $7.9B | 2024-01-01 – 2024-12-31 | evidence 0001156039-25-000010 |
| FY 2023 | $8.5B | 2023-01-01 – 2023-12-31 | evidence 0001156039-24-000015 |
| FY 2022 | $8.3B | 2022-01-01 – 2022-12-31 | evidence 0001156039-23-000109 |
| FY 2021 | $7.6B | 2021-01-01 – 2021-12-31 | evidence 0001156039-23-000109 |
| FY 2020 | $6.4B | 2020-01-01 – 2020-12-31 | evidence 0001156039-21-000012 |
| FY 2019 | $6.0B | 2019-01-01 – 2019-12-31 | evidence 0001156039-20-000003 |
| FY 2018 | $5.4B | 2018-01-01 – 2018-12-31 | evidence 0001156039-19-000004 |
| FY 2017 | $4.2B | 2017-01-01 – 2017-12-31 | evidence 0001156039-19-000004 |
| FY 2016 | $4.8B | 2016-01-01 – 2016-12-31 | evidence 0001156039-19-000004 |
| FY 2015 | $4.8B | 2015-01-01 – 2015-12-31 | evidence 0001156039-16-000018 |
| FY 2014 | $4.4B | 2014-01-01 – 2014-12-31 | evidence 0001156039-15-000003 |
| FY 2013 | $4.0B | 2013-01-01 – 2013-12-31 | evidence 0001156039-14-000003 |
| FY 2012 | $3.6B | 2012-01-01 – 2012-12-31 | evidence 0001156039-14-000003 |
| FY 2011 | $3.8B | 2011-01-01 – 2011-12-31 | evidence 0001193125-12-072739 |
| FY 2010 | $4.1B | 2010-01-01 – 2010-12-31 | evidence 0001193125-11-039172 |
| FY 2009 | $4.2B | 2009-01-01 – 2009-12-31 | evidence 0001193125-11-039172 |
| FY 2008 | $4.3B | 2008-01-01 – 2008-12-31 | evidence 0001193125-11-039172 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).